Grant Feeds

Subscribe to Grant Feeds feed
The documents in this feed originate from FederalRegister.gov which displays an unofficial web version of the daily Federal Register. The official electronic version in PDF format is also available as a link from the FederalRegister.gov website. For more information, please see https://www.federalregister.gov/reader-aids/policy/legal-status.
Updated: 1 hour 16 min ago

Curtis-Straus LLC: Application for Expansion of Recognition

Tue, 12/25/2018 - 23:00
In this notice, OSHA announces the application of Curtis- Straus LLC for expansion of recognition as a Nationally Recognized Testing Laboratory (NRTL) and presents the agency's preliminary finding to grant the application.

Findings of Research Misconduct

Tue, 12/25/2018 - 23:00
Findings of research misconduct have been made against Uthra Rajamani, Ph.D. (Respondent), former project scientist in the Induced Pluripotent Stem Cell Core Facility, Cedars-Sinai Medical Center (CSMC). Dr. Rajamani engaged in research misconduct in research supported by National Center for Advancing Translational Science (NCATS), National Institutes of Health (NIH), grant UL1 TR000124. The administrative actions, including supervision for a period of one (1) year, were implemented beginning on November 27, 2018, and are detailed below.

Medicare Program; Request for Renewal of Deeming Authority of the Utilization Review Accreditation Commission (URAC) for Health Maintenance Organizations and Preferred Provider Organizations

Tue, 12/25/2018 - 23:00
This proposed notice announces that CMS is considering granting approval of the Utilization Review Accreditation Commission's (URAC) renewal application for Medicare Advantage ``deeming authority'' of Health Maintenance Organizations and Preferred Provider Organizations. This new 6-year term of approval would begin on the date of publication of the final notice. This notice also announces a 30-day period for the public to submit comments on CMS' renewal of the application.

Notice of Final Federal Agency Actions on Proposed Highway in California

Tue, 12/25/2018 - 23:00
The FHWA, on behalf of Caltrans, is issuing this notice to announce actions taken by Caltrans that are final. The actions relate to a proposed highway project, [Interstate 605 (I-605)/Katella Avenue Interchange] in the City of Los Alamitos, County of Orange, State of California. Those actions grant licenses, permits, and approvals for the project.

Florida Power & Light Company; Turkey Point Nuclear Generating Unit Nos. 3 and 4

Tue, 12/25/2018 - 23:00
The U.S. Nuclear Regulatory Commission (NRC) is considering issuance of amendments to Renewed Facility Operating License Nos. DPR- 31 and DPR-41, issued to Florida Power & Light Company, for operation of Turkey Point Nuclear Generating Unit Nos. 3 and 4, respectively. The proposed amendments would modify Paragraph 3.D, ``Transition License Conditions,'' of the Renewed Facility Operating Licenses to delete Implementation Item 22. For this license amendment request (LAR), the NRC proposes to determine that it involves no significant hazards consideration. Because this LAR contains sensitive unclassified non- safeguards information (SUNSI), an order imposes procedures to obtain access to SUNSI for contention preparation.

Pacific Gas & Electric Company; Humboldt Bay Independent Spent Fuel Storage Installation; Renewal of Special Nuclear Materials License

Tue, 12/25/2018 - 23:00
The U.S. Nuclear Regulatory Commission (NRC) is considering an application for the renewal of Special Nuclear Materials (SNM) License No. SNM-2514, which currently authorizes Pacific Gas & Electric Company (PG&E) to receive, possess, transfer, and store spent fuel from Humboldt Bay Nuclear Power Plant (HPNPP) in the Humboldt Bay Independent Spent Fuel Storage Installation (ISFSI). The renewed license would authorize PG&E to continue to store spent fuel in the Humboldt Bay ISFSI for an additional 40 years beyond the current license expiration date of November 17, 2025.

Distribution of the 2007, 2008, 2009, 2010, and 2011 Digital Audio Recording Technology Royalty Funds for the Sound Recordings Funds

Tue, 12/25/2018 - 23:00
The Copyright Royalty Judges announce the commencement of a proceeding to determine the distribution of the digital audio recording technology royalty fees in the 2007, 2008, 2009, 2010, and 2011 Sound Recordings Funds. The Judges also announce the date by which a party who wishes to participate in this proceeding must file its Petition to Participate and the accompanying filing fee, if applicable.

Recreational Boating Safety Projects, Programs, and Activities Funded Under Provisions of the Fixing America's Surface Transportation Act; Fiscal Year 2018

Tue, 12/25/2018 - 23:00
The Coast Guard is publishing this notice to satisfy a requirement of the Fixing America's Surface Transportation Act that a detailed accounting of the projects, programs, and activities funded under the national recreational boating safety program provision of the Act be published annually in the Federal Register. This notice specifies the funding amounts the Coast Guard has committed, obligated, or expended during fiscal year 2018, as of September 30, 2018.

Notice of Closed Meeting

Tue, 12/25/2018 - 23:00

Notice of Closed Meeting

Tue, 12/25/2018 - 23:00

Notice of Closed Meeting

Tue, 12/25/2018 - 23:00

Notice of Closed Meeting

Tue, 12/25/2018 - 23:00

Taking and Importing Marine Mammals; Taking Marine Mammals Incidental to the U.S. Navy Training and Testing Activities in the Atlantic Fleet Training and Testing Study Area

Tue, 12/25/2018 - 23:00
NMFS has received a request from the U.S. Navy (Navy) to amend NMFS' Marine Mammal Protection Act (MMPA) regulations authorizing the take of marine mammals incidental to Navy training and testing activities conducted in the Atlantic Fleet Training and Testing (AFTT) Study Area from November 2018 to November 2023 to cover seven years of the Navy's activities, instead of five. Section 316 of the John S. McCain National Defense Authorization Act for Fiscal Year 2019 (2019 NDAA), signed into law on August 13, 2018, amended the MMPA to extend the maximum period for MMPA incidental take regulations under section 101(a)(5)(A) from five to seven years for military readiness activities. The Navy's activities qualify as military readiness activities pursuant to the MMPA, as amended by the NDAA for Fiscal Year 2004. The Navy proposes no changes to their specified activities, mitigation measures, monitoring, or reporting and requests that NMFS amend the final rule issued on November 14, 2018, to authorize incidental take of marine mammals for the two additional years now allowed under the statute. NMFS invites the public to provide information, suggestions, and comments on the Navy's application.

Agency Information Collection Activities; Proposed Collection; Public Comment Request; Inventory of Adult Protective Services Practices and Service Innovations

Tue, 12/25/2018 - 23:00
The Administration for Community Living (ACL) is announcing an opportunity for the public to comment on the proposed collection of certain information listed above. Under the Paperwork Reduction Act of 1995 (the PRA), Federal agencies are required to publish a notice in the Federal Register concerning each proposed collection of information, including each proposed extension of an existing collection of information, and to allow 60 days for public comment in response to the notice. This notice solicits comments on the information collection requirements relating to a new data collection (ICR New) effort titled ``Inventory of Adult Protective Services Practices and Service Innovations.''

Determination of Regulatory Review Period for Purposes of Patent Extension; ADLYXIN

Tue, 12/25/2018 - 23:00
The Food and Drug Administration (FDA or Agency) has determined the regulatory review period for ADLYXIN and is publishing this notice of that determination as required by law. FDA has made the determination because of the submission of an application to the Director of the U.S. Patent and Trademark Office (USPTO), Department of Commerce, for the extension of a patent which claims that human drug product.

Pages